Publications

Find coverage of the latest original articles on Lupus, focusing on those with data on therapeutic interventions and those that have clinical impact.

This activity is supported by an educational grant from AstraZeneca.

Anifrolumab, Mycophenolate mofetil, Sm-Tregs, CAR T-Cell, CV Risk factors,

October 2021

N Engl J Med. 2011;365(20):1886–95

MMF was superior to AZA in maintaining a renal response and preventing relapse in patients with LN who had a response to induction therapy.